Back

Dynamic changes in anaemia and phenotype-specific risk of adverse outcomes in patients with atrial fibrillation treated with NOACs

31 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation management: rhythm control, outcomes, and specific populations Sudden Death in Patients with Atrial Fibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Andrea Galeazzo Rigutini

University of Perugia, Perugia (Italy)

5 More presentations in this session

Presentation thumbnail
The RIBAT-AFRICA-AF Registry (Registry Initiative Across Borders for Atrial Fibrillation in Africa)
Professor A. Moustaghfir (Casablanca, MA)
Abstract Slides Video
Presentation thumbnail
Comparative clinical effectiveness and safety of amiodarone versus dronedarone in patients with atrial fibrillation
Miss L. Liu (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
The placebo effect in atrial fibrillation ablation: insights from a post hoc analysis of the PFA-SHAM trial
Doctor M. Hozman (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation and early-onset cognitive decline: a multicenter 14-year cross-sectional analysis of 1,641 patients in North Macedonia
Doctor V. Zhaku (Tetovo, MK)
Abstract Slides Video
Presentation thumbnail
Early rhythm control in patients with atrial fibrillation and cancer: a subgroup analysis of the EAST-AFNET 4 trial
Doctor D. Ismaili (Hamburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation management: rhythm control, outcomes, and specific populations

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Anaemia and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry
29 August 2022
thumbnail
Congress Presentation
Serial measurement of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in ENGAGE AF-TIMI 48
29 August 2020
thumbnail
Congress Presentation
Patterns of anticoagulant prescribing and renal function changes in patients with atrial fibrillation
27 August 2022
thumbnail
Congress Presentation
Non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs) in (morbidly) obese or low body weight patients with atrial fibrillation: a meta-analysis
23 April 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources